Skip to main content
. 2022 Jul 18;17(7):e0271580. doi: 10.1371/journal.pone.0271580

Table 1. Characteristics of included studies in the systematic review and meta-analysis.

Study Country Sample size (M/F) Ages (I/C) Surgical approach Control a Intervention Course of treatment Outcomes
Xu 2020 [33] China I: 16/14
C: 15/15
I: 28.55 ± 9.75
C: 29.64 ± 9.34
Open UC EA NA TFF, TBSR, LOS
Gu 2019 [35] China I: 31/27
C: 29/30
I: 57.59 ± 7.32
C: 56.67 ± 6.23
Laparoscopic SA TEAS From 30 min before anesthetic induction to 2 days after operation TFF, TFD, TBSR, VAS, AC, Incidence of PONV, Patient satisfaction
Pu 2019 [34] China I: 20/11
C: 16/15
I: 55.07 ± 10.17
C: 56.13 ± 11.08
Open UC EA 5 consecutive postoperative days TFF, TFD, TBSR, LOS, PSA
Chen 2018 [36] China I: 22/11
C: 24/6
I: 63.0 ± 9.70
C: 59.0 ± 8.30
Open, laparoscopic UC TEAS Starting on postoperative day 1, for 5 consecutive days or until passing flatus TFF, TFD, LOS, TNTR, TLSD, PSA
Kang 2017 [39] China I: 39/29
C: 41/27
I: 41.28 ± 10.36
C: 40.75 ± 10.19
Unclear UC EA NA TFF, TFD, TBSR, LOS, ADL
Jung 2017 [40] Korea I: 16/2
C: 16/2
I: 60.94 ± 9.43
C: 60.06 ± 13.18
Open, laparoscopic UC EA 5 consecutive postoperative days TFF, TFD, LOS, SWI, SSD, the number of remnant sitz markers in the small intestine on abdominal radiograph
Yuan 2017 [37] China I: 12/18
C: 16/14
I: 53.9 ± 9.8
C: 54.6 ± 10.4
Laparoscopic SA TEAS Half an hour before operation, then 3 consecutive postoperative days TFF, TBSR, LOS, Incidence of PONV, AC
Qian 2017 [38] China I: 20/10
C: 17/13
I: 59 ±10
C: 60 ± 11
Unclear UC MA 7 consecutive postoperative days TBSR, TFF, LOS, TGTR, IPAR, QOL, Hospitalization expenses
Zhang 2014 [41] China I: 11/8
C: 11/9
I: 63 ± 9
C: 60 ± 10
Open SA EA 30 min after operation, then 4 consecutive postoperative days TFF, TFD, TBSR,
Xiao 2014 [42] China I: 18/12
C1: 19/11
C2: 14/16
I: 55.87 ± 10.49
C1: 55.33 ± 10.83
C2: 54.63 ± 10.25
Open UC I1: EA
I2: MA
5 consecutive postoperative days TFF, TFD, TBSR, PSA
Tong 2014 [43] China I: 24/18
C: 26/16
I: 58.6 ± 15.1
C: 59.2 ± 14.7
Open UC MA 2 consecutive postoperative days TFF, TFD, TBSR, TLFI, TNTR, PSA
Wang 2013 [44] China I: 41/23
C: 43/21
I: 40.5 ± 9.7
C: 42.3 ± 9.1
Unclear UC MA 10 consecutive postoperative days TFF, TFD, TBSR
Ng 2013 [45] China I: 35/20
C1: 33/22
C2: 31/24
I: 67.4 ± 9.7
C1: 67.4 ± 10.7
C2: 68.5 ± 10.6
Laparoscopic C1: UC
C2: SA
EA Starting on postoperative day 1, for 4 consecutive days or until the first defecation TFF, TFD, LOS, TTSD, TWI, VAS, AC
Shi 2012 [46] China I: 15/15
C: 17/13
I: 53.17 ± 13.491
C: 53.77 ± 13.320
Unclear UC EA 3 consecutive postoperative days TFF, TFD, TBSR, PSA
Yang 2011 [47] China I: 21/10
C: 18/11
I: 60.9 ± 6.63
C: 62 ± 6.98
Unclear UC EA Starting on postoperative day 1 until 3 days after first defecation TFF, TFD, TBSR
Wang 2011 [48] China I: 11/4
C: 9/6
I: 58.0 ± 10.24
C: 60.4 ± 11.01
Open UC MA 5 consecutive postoperative days TFF, TFD, TBSR, PSA
Meng 2010 [50] China M: 47
F: 38
I: 54.3 (mean)
C: 53.1(mean)
Unclear UC EA Starting on postoperative day 1, for 6 consecutive days or until the first bowel movement TFF, TFD, EGEG, QOL
Garcia 2008 [49] America I: 25/13
C: 26/14
35–45: 14
46–55: 24
56–65: 26
66–75: 12
75: 1
Unclear UC EA Starting on postoperative day 1, for 4 consecutive days or until the first defecation TFF, TFD, LOS, AC, QOL

a Usual care included: routine nasogastric tubes, intravenous fluids, parenteral nutrition and early mobilization.

Abbreviations: I/C, Intervention group/Control group; M/F, Male/Female; MA, manual acupuncture; EA, electroacupuncture; TEAS, transcutaneous electrical acupoint stimulation; UC, usual care; SA, sham acupuncture; ERAS, enhanced recovery after surgery; NA, not available; TFF, time to first flatus; TBSR, time to bowel sounds recovery; LOS, length of hospital stay; TFD, time to first defecation; VAS, visual analogue scale; AC, analgesic consumption; PONV, postoperative nausea and vomiting; PSA, postoperative symptom assessment; TNTR, time to nasogastric tube removal; TLSD, time to liquid and semi-liquid diet; ADL, activities of daily living; SWI, start of water intake; SSD, start of soft diet; TGTR, time to gastric tube removal; IPAR, incidence of postoperative adverse reactions; QOL, quality of life status, including pain, nausea, insomnia, abdominal distention and general sense of well-being; TLFI, time to liquid food intake; TTSD, time to tolerated a solid diet; TWI, time to walk independently; EGEG, electro-gastroenterography.